This announcement is a separate document:
仙琚制药：关于全资子公司杭州能可爱心医疗科技有限公司拟吸收合并全资子公司杭州梓铭基因科技有限公司的公告
Xianju Pharmaceutical: Announcement on the intention of the wholly-owned subsidiary Hangzhou Nengcuaixin Medical Technology Co., Ltd. to absorb and merge the wholly-owned subsidiary Hangzhou Ziming Gene Technology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated